Sotagliflozin
3 NDCs across 1 manufacturer|0 Generic,3 Brand
▸ More about this market▾ Less
The brand product was first FDA-approved on May 26, 2023. In 2024, Medicare Part D spent $6 million on Sotagliflozin across 7,368 claims for 2,006 beneficiaries.
Sotagliflozin is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $19.74 to $20.46 per EA — a 4% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$19.74 – $20.46
per EA
7d Activity
avg -0.2% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing SOTAGLIFLOZIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
INPEFA 200 MG TABLET | $20.4601 per EA | -0.19% |
INPEFA 200 MG TABLET | $20.4601 per EA | -0.19% |
INPEFA 200 MG TABLET | $19.7358 per EA | — |
Frequently Asked Questions
How much does Medicare spend on Sotagliflozin?
In 2024, Medicare Part D spent $6 million on Sotagliflozin across 7,368 claims for 2,006 beneficiaries.
How many Sotagliflozin products are on the market?
The Sotagliflozin drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Sotagliflozin?
NADAC reference prices for Sotagliflozin range from $19.7358 to $20.4601 per EA — a 4% difference between cheapest and most expensive.
Which manufacturers make Sotagliflozin?
1 manufacturer lists Sotagliflozin in NADAC. Ranked by number of NDCs, the largest are Lexicon Pharmaceuticals, Inc. (3).
How has the price of Sotagliflozin changed recently?
Over the past 7 days, 0 Sotagliflozin NDCs rose and 2 fell, with a market-wide average change of -0.2%.